Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Other Non Operating Income (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Other Non Operating Income for 16 consecutive years, with $41000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income rose 147.67% to $41000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.1 million, a 316.99% increase, with the full-year FY2024 number at -$1.0 million, down 14542.86% from a year prior.
  • Other Non Operating Income was $41000.0 for Q3 2025 at Usana Health Sciences, down from $1.7 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.7 million in Q2 2025 to a low of -$1.2 million in Q1 2022.
  • A 5-year average of -$178277.8 and a median of -$239000.0 in 2022 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: crashed 445.4% in 2021, then surged 598.28% in 2025.
  • Usana Health Sciences' Other Non Operating Income stood at -$889000.0 in 2021, then plummeted by 32.28% to -$1.2 million in 2022, then soared by 68.71% to -$368000.0 in 2023, then dropped by 5.98% to -$390000.0 in 2024, then skyrocketed by 110.51% to $41000.0 in 2025.
  • Per Business Quant, the three most recent readings for USNA's Other Non Operating Income are $41000.0 (Q3 2025), $1.7 million (Q2 2025), and $756000.0 (Q1 2025).